| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/04/2009 | US7569544 drug biological conjugates used in the diagnosis, prophylaxis, or treatment of nervous system disorders or lysosomal storage diseases; drug delivery; blood brain barriers |
| 08/04/2009 | US7569539 Oral administration of calcitonin |
| 08/04/2009 | US7569537 Peptide antagonists for inhibiting heat shock protein (Hsp 16.3) of Mycobacterium tuberculosis |
| 08/04/2009 | US7569388 Transgenic plant; genetic engineering |
| 08/04/2009 | US7569387 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 08/04/2009 | US7569386 Chondroitin synthase gene and methods of making and using same |
| 08/04/2009 | US7569384 With improved shelf life and storage stability; expression vectors and host cells; therapeutic proteins are chemically or genetically fused to albumin; hypoglycemic agents, analgesics; retinopathy, cardiovascular disease, obesity, renal disease, neuropathy |
| 08/04/2009 | US7569374 HCV RNA-dependent RNA polymerase |
| 08/04/2009 | US7569363 Modified Cry3A toxins and nucleic acid sequences coding therefor |
| 08/04/2009 | US7569361 Thrombopoietin protein variants |
| 08/04/2009 | US7569357 High affinity TCR proteins and methods |
| 08/04/2009 | US7569356 Detecting the presence of a prostate cancer cell expressing a protein SGP28; immunoassay |
| 08/04/2009 | US7569352 Method for identifying modulators of the dioxin/aryl hydrocarbon receptor (AHR) |
| 08/04/2009 | US7569351 P53 dependent apoptosis-associated gene and protein |
| 08/04/2009 | US7569350 purifying extracellular nucleic acid from plasma or serum; amplifying; detecting the amplified nucleic acid fragment that is associated with neoplastic or proliferative disease in the amplified nucleic acid fraction |
| 08/04/2009 | US7569349 Methods for selecting monoclonal antibody therapies using extracellular DNA |
| 08/04/2009 | US7569229 Monocyte locomotion inhibitory factor |
| 08/04/2009 | US7569228 Fusion proteins of non-attenuated HIV regulatory/accessory proteins |
| 08/04/2009 | US7569227 Monomeric protein of the TGF-β family |
| 08/04/2009 | US7569226 Alkaline protease from Bacillus sp. (DSM 14392) and washing and cleaning products comprising said alkaline protease |
| 08/04/2009 | US7569224 Mammalian cytokines; receptors; related reagents and methods |
| 08/04/2009 | US7569219 Delivery of recombinant dsRNA phage to eukaryotic cells and tissues, either by direct administration, formulated in lipid or lactide-glycolide copolymer, or by utilizing a bacterial vaccine vector |
| 08/04/2009 | US7569218 Compositions for and methods of using herpes simplex virus glycoprotein D to suppress immune responses |
| 08/04/2009 | US7569217 Porcine adenovirus E1 and E4 regions |
| 08/04/2009 | US7569215 Mutant interleukin-2 (IL-2) polypeptides |
| 08/04/2009 | CA2331772C Hemoglobins to maintain cell energy status |
| 08/04/2009 | CA2323090C In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases |
| 08/04/2009 | CA2247009C Cryptic peptides and method for their identification |
| 08/04/2009 | CA2194673C A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 08/04/2009 | CA2109580C Plant medium-chain thioesterases |
| 07/30/2009 | WO2009094636A2 Ixodes scapularis salivary proteins and methods of use for modulation of the alternative complement pathway |
| 07/30/2009 | WO2009094634A1 Lytic domain fusion constructs and methods of making and using same |
| 07/30/2009 | WO2009094610A1 Novel cell lines expressing enac and methods using them |
| 07/30/2009 | WO2009094561A1 Induced internalization of surface receptors |
| 07/30/2009 | WO2009094527A2 Transcriptional activators involved in abiotic stress tolerance |
| 07/30/2009 | WO2009094202A1 Method of treating cancer, neoplastic disorders, and symptoms thereof with compounds |
| 07/30/2009 | WO2009094172A2 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage |
| 07/30/2009 | WO2009094006A2 Bordetella outer-membrane protein antigens and methods of making and using the same |
| 07/30/2009 | WO2009093918A1 A method of producing an n-blocked biphalin intermediate |
| 07/30/2009 | WO2009093917A2 Production of the opioid peptide biphaline |
| 07/30/2009 | WO2009093447A1 Anti-tumor agent for gastrointestinal cancer |
| 07/30/2009 | WO2009093246A2 Clusterin derived peptide |
| 07/30/2009 | WO2009092925A2 Production of cleistogamic plants |
| 07/30/2009 | WO2009092891A2 Modification of intrinsically disordered sequences for preparing vaccines |
| 07/30/2009 | WO2009092808A1 Method for detecting phosphopantetheinyl transferase activity |
| 07/30/2009 | WO2009092806A2 Selective exosite inhibition of papp-a activity against igfbp-4 |
| 07/30/2009 | WO2009092790A1 Listeria monocytogenes cytotoxin listeriolysin s |
| 07/30/2009 | WO2009092772A2 Plants having enhanced yield-related traits and a method for making the same |
| 07/30/2009 | WO2009092732A1 Proteinaceous binding molecules comprising purification tags or inert variable domains |
| 07/30/2009 | WO2009092612A1 Hydrophobic modified pres-derived peptides of hepatitis b virus (hbv) and their use as vehicles for the specific delivery of compounds to the liver |
| 07/30/2009 | WO2009092611A1 Hydrophobic modified pres-derived peptides of hepatitis b virus (hbv) and their use as hbv and hdv entry inhibitors |
| 07/30/2009 | WO2009092396A1 Hydrophobic modified pres-derived peptides of hepatitis b virus (hbv) and their use as hbv and hdv entry inhibitors |
| 07/30/2009 | WO2009074318A3 Novel rubella e1 envelope protein variants and their use in the detection of anti-rubella antibodies |
| 07/30/2009 | WO2009068042A3 Novel peptides derived from ncam (fgls) |
| 07/30/2009 | WO2009067580A3 Maize ethylene signaling genes and modulation of same for improved stress tolerance in plants |
| 07/30/2009 | WO2009067569A3 Plants with altered root architecture, related constructs and methods involving genes encoding leucine rich repeat kinase (llrk) polypeptides and homologs thereof |
| 07/30/2009 | WO2009062241A8 Crystal structure of a bacterial enzyme and uses thereof |
| 07/30/2009 | WO2009053725A3 Peptides and uses thereof |
| 07/30/2009 | WO2009045550A3 System for capturing and modifying large pieces of genomic dna and constructing organisms with synthetic chloroplasts |
| 07/30/2009 | WO2009026053A3 Inhibitors of iaspp interaction with an iaspp binding partner and methods of use |
| 07/30/2009 | WO2009025759A8 Tight junction proteins associated with infection and entry of hepatitis c virus (hcv), methods and uses thereof |
| 07/30/2009 | WO2009024280A3 Cell carrier containing collagen |
| 07/30/2009 | WO2008151197A8 Tumor-derived endogenous toll-like receptor 4 ligands |
| 07/30/2009 | WO2008148298A8 Improvement of cold tolerance in plants by protein kinase gene oscipk03 from rice |
| 07/30/2009 | WO2008145754A3 Ligands of hvem for treating hematologic malignancies and autoimmune diseases |
| 07/30/2009 | WO2008138348A8 Preparation of complexed lactalbumin |
| 07/30/2009 | WO2008119882A8 Screening methods based on human adam12 polypeptide and binding agents thereof |
| 07/30/2009 | WO2008101406A8 Modified mutant collagenase and it's use in fat melting and in scar reduction |
| 07/30/2009 | WO2008090263A8 Preli - a novel t-cell regulator |
| 07/30/2009 | WO2008085543A8 Multimeric elp fusion constructs |
| 07/30/2009 | WO2008077511A8 Human polyomavirus and methods of diagnosis and treatment |
| 07/30/2009 | WO2008067223A8 Il-17a/f heterodimeric polypeptides and therapeutic uses thereof |
| 07/30/2009 | WO2008055059A8 Bi-functional peptides for multiple sclerosis treatment and diagnosis |
| 07/30/2009 | WO2008046964A8 Novel useful inhibitors |
| 07/30/2009 | WO2007137591A8 Hiv vaccine |
| 07/30/2009 | WO2007112682A8 Recombinant human parathyroid hormone-related proteins and uses thereof |
| 07/30/2009 | WO2007104263A8 An enhancin of hepatitis b virus vaccine and its gene |
| 07/30/2009 | WO2007088460A8 Tgf-beta modulators and use thereof |
| 07/30/2009 | WO2007085923A8 Novel fluorescent proteins and methods for using same |
| 07/30/2009 | WO2007084985A8 Composition and method to increase mammalian sperm function |
| 07/30/2009 | US20090193540 Transgenic plant comprising vector coding Peronospora parasitica protein (PPR1) protein for propagating disease resistant plants; biological pest control; progenitor cells a vector is introduced into plant, growing a transgenic plant that expresses the nucleotide sequence |
| 07/30/2009 | US20090193539 Generation of plants with improved pathogen resistance |
| 07/30/2009 | US20090193538 Nucleic acid molecules and other molecules associated with the carbon assimilation pathway |
| 07/30/2009 | US20090192320 a polyalkylene glycol derivative having a reactive group, which can be combined with a bio-related substance, at the primary carbon at the 1-position of a glycerin skeleton and having polyalkylene glycol chains at the 2- and 3-positions |
| 07/30/2009 | US20090192298 Through-bond energy transfer cassettes, systems and methods |
| 07/30/2009 | US20090192296 Method for Producing Denatured Substance of Lactalbumin |
| 07/30/2009 | US20090192295 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
| 07/30/2009 | US20090192294 Magi polynucleotides, polypeptides, and antibodies |
| 07/30/2009 | US20090192293 Antibodies to non-functional p2x7 receptor |
| 07/30/2009 | US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides |
| 07/30/2009 | US20090192291 Production of homotrimeric fusion proteins |
| 07/30/2009 | US20090192290 New bacillus thuringiensis strains and their insecticidal proteins |
| 07/30/2009 | US20090192189 Treatment of cancers expressing p95 erbb2 |
| 07/30/2009 | US20090192109 Compositions for diagnosis and therapy of diseases associated with aberrant expression of Kremen and/or Wnt |
| 07/30/2009 | US20090192108 Gene overexpressed in cancer |
| 07/30/2009 | US20090192100 Novel use of spiegelmers |
| 07/30/2009 | US20090192092 Neuropeptides and Their Use for Pest Control |
| 07/30/2009 | US20090192090 Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity |
| 07/30/2009 | US20090192089 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 07/30/2009 | US20090192088 Vascular Endothelial Growth Factor 2 |